Ten patients with soft-tissue infections due to Staphylococcus aureus were treated with minocycline, a semisynthetic tetracycline with potent in vitro antistaphylococcal effects. Serum concentrations averaged three to five times the concentration of minocycline required to inhibit growth of S. aureus in vitro. Clearing of the infecting organism was slow (less than 50% of lesions were sterile on day 10 of therapy), but clinical improvement was noted in 8 of 10 patients.
Previous studies from this laboratory have demonstrated that therapy of open soft-tissue lesions infected with Staphylococcus aureus provides a convenient clinical model for the investigation of in vivo efficacy of antistaphylococcal antibiotics (7) . Disappearance of S. aureus from lesions during therapy can be correlated with antibiotic susceptibility, serum antibiotic concentrations, and rapidity of clinical healing. We are reporting results of treatment of staphylococcal soft-tissue lesions in 10 patients with minocycline, a semisynthetic tetracycline with potent antistaphylococcal activity (4, 6, 8, 10, 12) .
MATERIALS AND METHODS
Ten patients with soft-tissue lesions infected with S. aureus received 11 courses of minocycline. Eight patients had abscesses of the buttocks, sacrum, and lower limb, and two had carbuncles, one on the thigh and one on the forearm. The patients were afebrile and did not have leukocytosis, but did have local discomfort in the affected areas. Minocycline was administered for 8 to 18 days. The average length of therapy was 10 days. In addition, all lesions were treated locally with soaks and debridement when necessary. Cultures were obtained Monday through Friday after initiation of minocycline to evaluate, semiquantitatively, the efficacy of therapy. Cultures were taken with a sterile dry cotton swab applied to the surface of the lesions and subsequently streaked over a mannitol-salt agar plate. The plates were incubated for 48 h at 37 C. The number of colonies was estimated and recorded as: (i) too numerous to count, (ii) 200 or fewer colonies, (iii) 50 or fewer colonies, and (iv) negative. Three colonies were picked from each plate for antibiotic susceptibility testing and phage typing.
Susceptibility to multiple antibiotics was determined by the single disk test of Bauer et al. (1) . Minimal inhibitory concentrations (MIC) of both tetracycline and minocycline were determined by the standard twofold broth dilution method in a final volume of 1 ml. A 0.5-ml amount of brain heart infusion broth (Difco) was pipetted into a series of test tubes (1.3 by 10 cm), and 0.5 ml of a solution of the antibiotic was then serially diluted in a twofold manner. The last tube contained no antibiotic and served as a positive control. A 0.4-ml volume of brain heart infusion broth was added to each tube. Lastly, 0.1 ml of a 10-2 dilution of an 18-h culture of the S. aureus to be tested was inoculated into each tube to make the final concentration of the inoculum 10-3 organisms per ml (ca. 106 colony-forming units). The MIC was read as that concentration of antibiotic in the last clear tube next to the first tube cloudy with growth after 18 h of incubation at 37 C. Minimal bactericidal concentrations were determined by a further 18 h of incubation of the test at 37 C and read the same way as the MICs. Phage typing was performed by a standard manner (3) with a replicate plate technique previously described (11) .
Sera were obtained at various intervals after administration of minocycline. The concentration was determined by the agar well diffusion technique of Bennett et al. with Bacillus cereus as the test organism (2) .
Minocycline was administered orally and given at an initial dose of 200 mg followed by 100 mg every 12 h. No untoward side effects were noted.
RESULTS
Cultures from the 10 patients grew penicillinresistant S. aureus susceptible to minocycline. Six isolates were resistant to tetracycline. Six were phage group I, two were untypable, one was a group Ill type 84/85, and one was not typed (Table 1) .
All the lesions yielded S. aureus too numerous to count when initially cultured. Repeat culture obtained from seven patients after 4 days of therapy revealed that three grew 50 colonies or Serum concentrations were measured in five patients following oral administration of 100 mg of minocycline (Table 2 ). Blood levels greater than concentrations required to inhibit growth of the infecting organism were recorded up to 9 h; at 11 h the levels were often equal to or lower than the MIC of the infecting organism. There appeared to be no accumulation of the drug as determined by assays obtained later in the treatment period. DISCUSSION Previous studies have demonstrated that 80 to 90% of daily cultures obtained from soft-tissue lesions in patients receiving either cloxacillin or oxacillin become negative by day 9 of therapy. In contrast, only 12% of daily cultures obtained from lesions treated locally without systemic antibiotics become negative by day 17 of treatment (7) . Minocycline therapy resulted in negative cultures in less than 50% of cultures obtained on day 10. Although it is difficult to compare results of therapy carried out in different time periods, these results are less impressive than those achieved with semisynthetic penicillins.
The enhanced antistaphylococcal activity of minocycline noted in vitro is probably explained by an increased uptake of minocycline by S. aureus. In contrast, tetracycline-resistant S. aureus accumulate less tetracycline than sensitive strains (8) . However, the bactericidal activity of minocycline against S. aureus in vitro is slow. Ten to fourteen days are required for concentrations of this agent, maintained at 10 to 50 times the MIC necessary to sterilize a 50-ml flask containing an inoculum of 5 x 106 to 1 x 107 colony-forming units per ml of a susceptible S. aureus (5) . In contrast to these high concentrations utilized in vitro, serum 
